Choice of hormonal therapy for prostate cancer
Six decades ago Huggins and Hodges established that the initial growth of prostate cancer is dependent on testosterone. The type of hormonal therapy selected, and its timing, ultimately rely on informed decision-making by patient and physician.
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 2000-04, Vol.355 (9214), p.1474-1475 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1475 |
|---|---|
| container_issue | 9214 |
| container_start_page | 1474 |
| container_title | The Lancet (British edition) |
| container_volume | 355 |
| creator | Reese, David M |
| description | Six decades ago Huggins and Hodges established that the initial growth of prostate cancer is dependent on testosterone. The type of hormonal therapy selected, and its timing, ultimately rely on informed decision-making by patient and physician. |
| doi_str_mv | 10.1016/S0140-6736(00)02155-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71091031</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673600021553</els_id><sourcerecordid>71091031</sourcerecordid><originalsourceid>FETCH-LOGICAL-c454t-bc8aeb9e190354c451a483ac4f8cb9e9842c742404e5528d78c848efd081c2ba3</originalsourceid><addsrcrecordid>eNqFkE1Lw0AQhhdRbP34CUrwIHpInUl2k81JpPgFBQ8qeFs2mwlNabt1NxH67902RcSLp4HheedlHsbOEEYImN28AnKIszzNrgCuIUEh4nSPDZHnPBY8_9hnwx9kwI68nwEAz0AcsgGCBMQsGbLReGobQ5Gto6l1C7vU86idktOrdVRbF62c9a1uKTJ6acidsINazz2d7uYxe3-4fxs_xZOXx-fx3SQ2XPA2Lo3UVBaEBaSChx1qLlNteC1NWBeSJybnCQdOQiSyyqWRXFJdgUSTlDo9Zpf93dD_2ZFv1aLxhuZzvSTbeZUjFAgpBvDiDziznQtfeIWFDEVpJgMkesiEb7yjWq1cs9BurRDUxqba2lQbVQpAbW2qNOTOd8e7ckHVr1SvLwC3PUDBxVdDTnnTUBBVNY5Mqyrb_FPxDemzggo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198984368</pqid></control><display><type>article</type><title>Choice of hormonal therapy for prostate cancer</title><source>MEDLINE</source><source>EBSCOhost Business Source Complete</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Reese, David M</creator><creatorcontrib>Reese, David M</creatorcontrib><description>Six decades ago Huggins and Hodges established that the initial growth of prostate cancer is dependent on testosterone. The type of hormonal therapy selected, and its timing, ultimately rely on informed decision-making by patient and physician.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(00)02155-3</identifier><identifier>PMID: 10801162</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Androgen Antagonists - therapeutic use ; Castration ; Drug therapy ; Hormones ; Humans ; Male ; Middle Aged ; Prostate cancer ; Prostatic Neoplasms - drug therapy ; Prostatic Neoplasms - surgery</subject><ispartof>The Lancet (British edition), 2000-04, Vol.355 (9214), p.1474-1475</ispartof><rights>2000 Elsevier Ltd</rights><rights>Copyright Lancet Ltd. Apr 29, 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c454t-bc8aeb9e190354c451a483ac4f8cb9e9842c742404e5528d78c848efd081c2ba3</citedby><cites>FETCH-LOGICAL-c454t-bc8aeb9e190354c451a483ac4f8cb9e9842c742404e5528d78c848efd081c2ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/198984368?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993,64383,64385,64387,72239</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10801162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reese, David M</creatorcontrib><title>Choice of hormonal therapy for prostate cancer</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Six decades ago Huggins and Hodges established that the initial growth of prostate cancer is dependent on testosterone. The type of hormonal therapy selected, and its timing, ultimately rely on informed decision-making by patient and physician.</description><subject>Androgen Antagonists - therapeutic use</subject><subject>Castration</subject><subject>Drug therapy</subject><subject>Hormones</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms - drug therapy</subject><subject>Prostatic Neoplasms - surgery</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkE1Lw0AQhhdRbP34CUrwIHpInUl2k81JpPgFBQ8qeFs2mwlNabt1NxH67902RcSLp4HheedlHsbOEEYImN28AnKIszzNrgCuIUEh4nSPDZHnPBY8_9hnwx9kwI68nwEAz0AcsgGCBMQsGbLReGobQ5Gto6l1C7vU86idktOrdVRbF62c9a1uKTJ6acidsINazz2d7uYxe3-4fxs_xZOXx-fx3SQ2XPA2Lo3UVBaEBaSChx1qLlNteC1NWBeSJybnCQdOQiSyyqWRXFJdgUSTlDo9Zpf93dD_2ZFv1aLxhuZzvSTbeZUjFAgpBvDiDziznQtfeIWFDEVpJgMkesiEb7yjWq1cs9BurRDUxqba2lQbVQpAbW2qNOTOd8e7ckHVr1SvLwC3PUDBxVdDTnnTUBBVNY5Mqyrb_FPxDemzggo</recordid><startdate>20000429</startdate><enddate>20000429</enddate><creator>Reese, David M</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20000429</creationdate><title>Choice of hormonal therapy for prostate cancer</title><author>Reese, David M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c454t-bc8aeb9e190354c451a483ac4f8cb9e9842c742404e5528d78c848efd081c2ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Androgen Antagonists - therapeutic use</topic><topic>Castration</topic><topic>Drug therapy</topic><topic>Hormones</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms - drug therapy</topic><topic>Prostatic Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reese, David M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reese, David M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Choice of hormonal therapy for prostate cancer</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2000-04-29</date><risdate>2000</risdate><volume>355</volume><issue>9214</issue><spage>1474</spage><epage>1475</epage><pages>1474-1475</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Six decades ago Huggins and Hodges established that the initial growth of prostate cancer is dependent on testosterone. The type of hormonal therapy selected, and its timing, ultimately rely on informed decision-making by patient and physician.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>10801162</pmid><doi>10.1016/S0140-6736(00)02155-3</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 2000-04, Vol.355 (9214), p.1474-1475 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71091031 |
| source | MEDLINE; EBSCOhost Business Source Complete; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
| subjects | Androgen Antagonists - therapeutic use Castration Drug therapy Hormones Humans Male Middle Aged Prostate cancer Prostatic Neoplasms - drug therapy Prostatic Neoplasms - surgery |
| title | Choice of hormonal therapy for prostate cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A07%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Choice%20of%20hormonal%20therapy%20for%20prostate%20cancer&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Reese,%20David%20M&rft.date=2000-04-29&rft.volume=355&rft.issue=9214&rft.spage=1474&rft.epage=1475&rft.pages=1474-1475&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(00)02155-3&rft_dat=%3Cproquest_cross%3E71091031%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=198984368&rft_id=info:pmid/10801162&rft_els_id=S0140673600021553&rfr_iscdi=true |